Skip to main content

Table 5 Adverse events (N = 13)

From: A phase II, open-label clinical trial on the combination therapy with medium-chain triglycerides and ghrelin in patients with chronic obstructive pulmonary disease

Adverse events

5-day MCT treatment

3-week ghrelin and MCT combination treatment

Unclearly related with the trial intervention

 Loose stools

 

5

 Stomach rumbling

 

1

 Feeling of being warm

 

2

 Slight elevation of CRP

 

2

 Slight liver dysfunction

 

1

Considered not to be related with the trial intervention

 Bronchial asthma

1

 

 Cerebral infarction

1

 

 Influenza infection

 

1

  1. Data are presented as the number of patients
  2. CRP C-reactive protein, MCT medium-chain triglyceride